Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Page 1
Subclinical Vascular Brain Lesions in Young Adults With Acute Ischemic Stroke.
De Giuli V, Grassi M, Besana M, Zedde M, Zini A, Lodigiani C, Marcheselli S, Cavallini A, Micieli G, Rasura M, DeLodovici ML, Tomelleri G, Checcarelli N, Chiti A, Giorli E, Del Sette M, Tancredi L, Toriello A, Braga M, Morotti A, Pezzini D, Locatelli M, Mazzoleni V, Bonacina S, Gamba M, Magoni M, Patella R, Spalloni A, Maria Simone A, Pascarella R, Beretta S, Padovani A, Gasparotti R, Pezzini A; Italian Project on Stroke in Young Adults (IPSYS) Investigators. De Giuli V, et al. Among authors: tomelleri g. Stroke. 2022 Apr;53(4):1190-1198. doi: 10.1161/STROKEAHA.121.036038. Epub 2021 Nov 3. Stroke. 2022. PMID: 34727743
Little is known about predisposing factors and their impact on long-term outcome of patients with stroke at a young age. METHODS: We quantified magnetic resonance-defined subclinical vascular brain lesions, including lacunes and white matter hyperintensities, perivascular …
Little is known about predisposing factors and their impact on long-term outcome of patients with stroke at a young age. METHODS: We …
Clinical outcomes of secondary prevention strategies for young patients with cryptogenic stroke and patent foramen ovale.
Danese A, Stegagno C, Tomelleri G, Piccoli A, Turri G, Carletti M, Variola A, Anselmi M, Mazzucco S, Ferrara A, Bovi P, Micheletti N, Cappellari M, Monaco S, Vassanelli C, Ribichini F; Verostroke Group. Danese A, et al. Among authors: tomelleri g. Acta Cardiol. 2017 Aug;72(4):410-418. doi: 10.1080/00015385.2017.1307668. Epub 2017 Jul 14. Acta Cardiol. 2017. PMID: 28705105
Background The aim of this study was to compare the immediate and long-term clinical outcomes of medical therapy and percutaneous patent foramen ovale (PFO) closure as secondary prevention strategies in patients younger than 55 years of age presenting with cryptogenic stro …
Background The aim of this study was to compare the immediate and long-term clinical outcomes of medical therapy and percutaneous pat …
Predictors of long-term recurrent vascular events after ischemic stroke at young age: the Italian Project on Stroke in Young Adults.
Pezzini A, Grassi M, Lodigiani C, Patella R, Gandolfo C, Zini A, Delodovici ML, Paciaroni M, Del Sette M, Toriello A, Musolino R, Calabrò RS, Bovi P, Adami A, Silvestrelli G, Sessa M, Cavallini A, Marcheselli S, Bonifati DM, Checcarelli N, Tancredi L, Chiti A, Del Zotto E, Spalloni A, Giossi A, Volonghi I, Costa P, Giacalone G, Ferrazzi P, Poli L, Morotti A, Rasura M, Simone AM, Gamba M, Cerrato P, Micieli G, Melis M, Massucco D, De Giuli V, Iacoviello L, Padovani A; Italian Project on Stroke in Young Adults (IPSYS) Investigators. Pezzini A, et al. Circulation. 2014 Apr 22;129(16):1668-76. doi: 10.1161/CIRCULATIONAHA.113.005663. Epub 2014 Feb 7. Circulation. 2014. PMID: 24508827
BACKGROUND: Data on long-term risk and predictors of recurrent thrombotic events after ischemic stroke at a young age are limited. ...CONCLUSIONS: Among patients with ischemic stroke aged 18 to 45 years, the long-term risk of recurrent thrombotic events is associate …
BACKGROUND: Data on long-term risk and predictors of recurrent thrombotic events after ischemic stroke at a young age are limited. .. …
Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke.
Cappellari M, Moretto G, Micheletti N, Donato F, Tomelleri G, Gulli G, Carletti M, Squintani GM, Zanoni T, Ottaviani S, Romito S, Tommasi G, Musso AM, Deotto L, Gambina G, Zimatore DS, Bovi P. Cappellari M, et al. Among authors: tomelleri g. J Thromb Thrombolysis. 2014 May;37(4):549-56. doi: 10.1007/s11239-013-0980-2. J Thromb Thrombolysis. 2014. PMID: 23943338 Clinical Trial.
Early neurological status after thrombolysis could identify more faithfully the impact of off-label Alteplase use that long-term functional outcome. We aimed to identify the impact of off-label thrombolysis and each off-label criterion on early clinical outcomes compared w …
Early neurological status after thrombolysis could identify more faithfully the impact of off-label Alteplase use that long-term func …
Critical illness myopathy.
Latronico N, Tomelleri G, Filosto M. Latronico N, et al. Among authors: tomelleri g. Curr Opin Rheumatol. 2012 Nov;24(6):616-22. doi: 10.1097/BOR.0b013e3283588d2f. Curr Opin Rheumatol. 2012. PMID: 22918529 Review.
PURPOSE OF REVIEW: To describe the incidence, major risk factors, and the clinical, electrophysiological, and histological features of critical illness myopathy (CIM). Major pathogenetic mechanisms and long-term consequences of CIM are also reviewed. RECENT FINDINGS: CIM i …
PURPOSE OF REVIEW: To describe the incidence, major risk factors, and the clinical, electrophysiological, and histological features of criti …
Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy.
Filosto M, Scarpelli M, Tonin P, Lucchini G, Pavan F, Santus F, Parini R, Donati MA, Cotelli MS, Vielmi V, Todeschini A, Canonico F, Tomelleri G, Padovani A, Rovelli A. Filosto M, et al. Among authors: tomelleri g. J Neurol. 2012 Dec;259(12):2699-706. doi: 10.1007/s00415-012-6572-9. Epub 2012 Jun 19. J Neurol. 2012. PMID: 22711161
Allogeneic hematopoietic stem cell transplantation (HSCT) has been proposed as a treatment for patients with MNGIE and a standardized approach to HSCT in this condition has recently been developed. We report on the transplant course, management and short-term follow-up in …
Allogeneic hematopoietic stem cell transplantation (HSCT) has been proposed as a treatment for patients with MNGIE and a standardized approa …
Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathy.
Vattemi G, Neri M, Piffer S, Vicart P, Gualandi F, Marini M, Guglielmi V, Filosto M, Tonin P, Ferlini A, Tomelleri G. Vattemi G, et al. Among authors: tomelleri g. Acta Myol. 2011 Oct;30(2):121-6. Acta Myol. 2011. PMID: 22106715 Free PMC article.
The term myofibrillar myopathies (MFM) refers to uncommon neuromuscular disorders that pathologically are characterized by myofibrillar degeneration and ectopic expression of several proteins. ...
The term myofibrillar myopathies (MFM) refers to uncommon neuromuscular disorders that pathologically are characterized by myofibrill …
Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study.
Cappellari M, Deluca C, Tinazzi M, Tomelleri G, Carletti M, Fiaschi A, Bovi P, Moretto G. Cappellari M, et al. Among authors: tomelleri g. J Neurol Sci. 2011 Sep 15;308(1-2):128-34. doi: 10.1016/j.jns.2011.05.026. Epub 2011 Jun 16. J Neurol Sci. 2011. PMID: 21683374
The aim of the present study was to assess whether statin treatment started in the acute phase of stroke (within 24h) or before stroke and continued during the acute phase may influence short- and long-term outcome in patients receiving intravenous (IV) thrombolysis. ...CO …
The aim of the present study was to assess whether statin treatment started in the acute phase of stroke (within 24h) or before stroke and c …
Neuropathology of mitochondrial diseases.
Filosto M, Tomelleri G, Tonin P, Scarpelli M, Vattemi G, Rizzuto N, Padovani A, Simonati A. Filosto M, et al. Among authors: tomelleri g. Biosci Rep. 2007 Jun;27(1-3):23-30. doi: 10.1007/s10540-007-9034-3. Biosci Rep. 2007. PMID: 17541738 Review.
The term "mitochondrial diseases" (MD) refers to a group of disorders related to respiratory chain dysfunction. ...
The term "mitochondrial diseases" (MD) refers to a group of disorders related to respiratory chain dysfunction. ...
Expression of protein kinase C isoforms and interleukin-1beta in myofibrillar myopathy.
Vattemi G, Tonin P, Mora M, Filosto M, Morandi L, Savio C, Dal Pra I, Rizzuto N, Tomelleri G. Vattemi G, et al. Among authors: tomelleri g. Neurology. 2004 May 25;62(10):1778-82. doi: 10.1212/01.wnl.0000125197.70310.8e. Neurology. 2004. PMID: 15159477
BACKGROUND: The term myofibrillar myopathy refers to a rare and clinically heterogeneous group of muscle disorders. ...
BACKGROUND: The term myofibrillar myopathy refers to a rare and clinically heterogeneous group of muscle disorders. ...
12 results